ALX Oncology Holdings Inc — Stato Patrimoniale (NASDAQ:ALXO) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Totale attivo 436.05 M380.18 M306.49 M242.55 M147.78 M59.05 M Totale passività 6.21 M17.13 M43.02 M52.84 M34.16 M33.06 M Patrimonio netto totale 429.85 M363.05 M263.46 M189.71 M113.62 M25.98 M Totale passività e patrimonio netto 436.05 M380.18 M306.49 M242.55 M147.78 M59.05 M Debito totale 5.42 M—9.68 M10.37 M10.87 M10.71 M Indebitamento netto -428.8 M—-256.53 M-172.37 M-116.89 M-34.08 M

Notizie

ALX Oncology nomina Jeff Knight Chief Development Officer

Wells Fargo avvia copertura su ALX Oncology con rating overweight

ALDX Crashes 71% as FDA Issues Third CRL for Dry Eye Disease Drug NDA

CTMX Stock Rallies on Strong Phase I Colorectal Cancer Study Data

IBRX Stock Jumps on Progress in NK Cell Therapy Production

JNJ's Bladder Cancer Therapy Meets Key Goal in Early-Stage Study

RARE's DTX301 Meets First Key Goal in Phase III OTC Deficiency Study

RLMD Stock Surges 42% in a Week: Here's What You Should Know

GSK Out-Licenses Rights for Rare Liver Disease Drug to Alfasigma

EDIT Stock Up on Narrower-Than-Expected Q4 Loss, Revenues Rise Y/Y

Roche's Giredestrant Misses Key Goal in First-Line Breast Cancer Study

LRMR Stock on the Move: What Sparked the 55% Jump in the Past Month?